Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06015295 · ClinicalTrials.gov registry record · NA

A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy

A NA study of Brain Metastases, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06015295 is a NA study of Brain Metastases that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants, below the 213-participant average among 67 other Brain Metastases trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06015295, a NA study of Brain Metastases, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

To learn if 18F-Fluciclovine (Axumin) PET-CT scans can be used to better detect brain metastatic lesions in patients who are receiving immunotherapy.

Conditions Studied

Brain Metastases

Interventions

  • DIAGNOSTIC_TEST 18F-Fluciclovine (Axumin)
  • DIAGNOSTIC_TEST Pet Scan

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-11-07
Est. Completion 2028-03-30
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06015295

The ClinicalTrials.gov registry entry for NCT06015295 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 213-participant average among 67 other Brain Metastases trials with a reported enrollment target (91% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Metastases appearing as the primary indexed condition, and to 2 interventions - of which 18F-Fluciclovine (Axumin) is the first listed.

NCT06015295 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06015295 about?

NCT06015295 is a clinical study titled "A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy". To learn if 18F-Fluciclovine (Axumin) PET-CT scans can be used to better detect brain metastatic lesions in patients who are receiving immunotherapy.

What is the current status of trial NCT06015295?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-11-07. Estimated completion is 2028-03-30.

What conditions does trial NCT06015295 study?

This clinical trial studies the following conditions: Brain Metastases.

What interventions are being tested in trial NCT06015295?

The interventions under investigation include: 18F-Fluciclovine (Axumin) (DIAGNOSTIC_TEST), Pet Scan (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06015295?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06015295 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Brain Metastases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Brain Metastases

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.